| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |